Biology

New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. Drug patent…
The post New tentative approval for Watson Labs drug dienogest; estradiol valerate appeared first on DrugPatentWatch – Make Better Decisions.

The post New tentative approval for Watson Labs drug dienogest; estradiol valerate appeared first on Biotechblog.

Source link




Related posts

New tentative approval for Watson Labs drug dienogest; estradiol valerate

Newsemia

Keck Medicine of USC announces launch of USC Epilepsy Care Consortium

Newsemia

A Selection of Recent News in Parkinson's Disease Research

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy